|
07.09.2015 16:42:00
|
Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital August 2015
Regulatory News:
ERYTECH PHARMA (Paris:ERYP) (ADR:EYRYY):
Listing market : Euronext Paris from Euronext
Market segment :
segment B
ISIN Code : FR0011471135
website : www.erytech.com
| Date |
Total of shares composing |
Total of brut(1) voting |
Total of net(2) voting |
|||
| 31 January 2015 | 6 882 761 | 8 090 321 | 8 085 071 | |||
| 28 February 2015 | 6 886 441 | 8 094 001 | 8 092 501 | |||
| 31 March 2015 | 6 886 941 | 8 094 301 | 8 091 801 | |||
| 30 April 2015 | 6 888 441 | 8 043 911 | 8 041 411 | |||
| 06 May 2015 | 6 888 441 | 8 733 677(3) | 8 731 177 | |||
| 31 May 2015 | 6 888 441 | 8 728 137 | 8 725 637 | |||
| 30 June 2015 | 6 889 291 | 8 675 087 | 8 672 587 | |||
| 31 July 2015 | 6 896 791(4) | 8 687 487 | 8 684 987 | |||
| 31 August 2015 | 6 901 641 | 8 686 137 | 8 683 637 |
(1)
Gross voting rights number (or « theoretical » voting
rights) is used as a calculus base for the crossing of the threshold. In
accordance with article 223-11 of general regulation of Autorité des
Marchés Financiers, this number is calculated on the basis of all shares
carrying the single and double voting rights, including shares without
voting rights.
(2) Without treasury shares
(3)
The total number of voting rights raised significantly due to the
acquisition of double voting rights related to shares namely owned for
more than two years.
(4)
The total of shares
composing the share capital has increased with the exercise of
securities giving access to the share capital. Capital increase will be
recorded during the next Board of Directors.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150907005344/en/
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ERYTECH PHARMAmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu ERYTECH PHARMAmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.